Announcements from major health organizations (e.g., FDA, EMA, WHO)

New Ultra-Sensitive Blood Test from London's Institute Predicts Breast Cancer Recurrence with 100% Accuracy

Jun 2, 2024, 02:55 PM

Researchers in the UK have developed an ultra-sensitive blood test that can predict if breast cancer will return years before it shows up on scans. This breakthrough test, developed by scientists at London's Institute of Cancer Research, boasts 100% accuracy and detects circulating tumor DNA. It allows for early intervention, potentially preventing the disease from becoming incurable. The test has been hailed as incredibly exciting and marks a significant advancement in the early detection of breast cancer recurrence.